VOLUME 20 – SPECIAL EDITION
Pharmacy in Practice
Pharmacy in Practice (PiP) is a recognised and respected
title for decision-makers within acute trusts and
primary care organisations.
Volume 20 is a sole-sponsored supplement funded by Bristol-Myers Squibb and sanofi-aventis.
New webcast now available
Watch Ingrid Torjensen, Freelance Journalist and Opinion Editor
of the Health Service Journal interview Gail Chan, Team Leader
for a Practice Based Commissioning Group in Liverpool about
her considerations when deciding whether or not to
recommend a generic switch.
Now published – three new articles
Recent Government consultation on generic substitution has sparked debates about the differences between generic and therapeutic substitution, the financial implications of switching and concerns over reduced compliance and patient perceptions of generic products.
With further debate on generic substitution, this article reviews the literature to consider the pros and cons of generic prescribing…
Perceptions on generic prescribing vary from healthcare professionals to patients – here we debate the real issues and cost considerations associated with generic switching…
One of the markets recently hit with generics is the ARB market; this article
reviews the implications of generic losartan and provides some considerations
for local decision-makers…
If you would like to sponsor a PiP supplement please contact pip@medicomgroup.com
|
All rights reserved 2010